Compile Data Set for Download or QSAR
maximum 50k data
Found 5978 of ic50 data for polymerid = 50006438,5447,5449
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559715(WO2022109117, Example 60)
Affinity DataIC50:  0.0400nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM50601261(CHEMBL5196538)
Affinity DataIC50:  0.0400nMAssay Description:Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559716(WO2022109117, Example 61)
Affinity DataIC50:  0.0500nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM50601262(CHEMBL5194793)
Affinity DataIC50:  0.0500nMAssay Description:Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM50601264(CHEMBL5177846)
Affinity DataIC50:  0.0700nMAssay Description:Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559737(WO2022109117, Example 82)
Affinity DataIC50:  0.0700nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559656(WO2022109117, Example 1)
Affinity DataIC50:  0.0900nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM50601259(CHEMBL5195414)
Affinity DataIC50:  0.0900nMAssay Description:Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559734(WO2022109117, Example 79)
Affinity DataIC50:  0.100nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM50601260(CHEMBL5190821)
Affinity DataIC50:  0.100nMAssay Description:Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559675(WO2022109117, Example 20)
Affinity DataIC50:  0.100nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559670(WO2022109117, Example 15 | WO2022109117, Example 1...)
Affinity DataIC50:  0.100nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM50601263(CHEMBL5206338)
Affinity DataIC50:  0.100nMAssay Description:Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559657(WO2022109117, Example 2)
Affinity DataIC50:  0.110nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559711(WO2022109117, Example 56)
Affinity DataIC50:  0.110nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559745(WO2022109117, Example 90)
Affinity DataIC50:  0.110nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559747(WO2022109117, Example 92)
Affinity DataIC50:  0.130nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559712(WO2022109117, Example 57)
Affinity DataIC50:  0.130nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559658(WO2022109117, Example 3)
Affinity DataIC50:  0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559673(WO2022109117, Example 18)
Affinity DataIC50:  0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559725(WO2022109117, Example 70)
Affinity DataIC50:  0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559760(WO2022109117, Example 105)
Affinity DataIC50:  0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559759(WO2022109117, Example 104)
Affinity DataIC50:  0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559736(WO2022109117, Example 81)
Affinity DataIC50:  0.160nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559697(WO2022109117, Example 42)
Affinity DataIC50:  0.170nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559669(WO2022109117, Example 14)
Affinity DataIC50:  0.180nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559670(WO2022109117, Example 15 | WO2022109117, Example 1...)
Affinity DataIC50:  0.180nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559668(WO2022109117, Example 13)
Affinity DataIC50:  0.200nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559726(WO2022109117, Example 71)
Affinity DataIC50:  0.210nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559758(WO2022109117, Example 103)
Affinity DataIC50:  0.210nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559722(WO2022109117, Example 67)
Affinity DataIC50:  0.220nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559677(WO2022109117, Example 22)
Affinity DataIC50:  0.230nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559735(WO2022109117, Example 80)
Affinity DataIC50:  0.230nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM514632(US11098029, Example 67)
Affinity DataIC50:  0.230nMAssay Description:Agonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as increase in intracellular Ca2+ mobilization by measuring IP3 producti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM514601(US11098029, Example 37)
Affinity DataIC50:  0.230nMAssay Description:In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM50561747(CHEMBL4740509)
Affinity DataIC50:  0.230nMAssay Description:Agonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as increase in intracellular Ca2+ mobilization by measuring IP3 producti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM514590(US11098029, Example 26)
Affinity DataIC50:  0.230nMAssay Description:In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559729(WO2022109117, Example 74)
Affinity DataIC50:  0.240nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559702(WO2022109117, Example 47)
Affinity DataIC50:  0.25nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559721(WO2022109117, Example 66)
Affinity DataIC50:  0.270nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM514589(US11098029, Example 25)
Affinity DataIC50:  0.270nMAssay Description:Agonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as increase in intracellular Ca2+ mobilization by measuring IP3 producti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM514589(US11098029, Example 25)
Affinity DataIC50:  0.270nMAssay Description:In a typical experiment, the OX1 and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559699(WO2022109117, Example 44)
Affinity DataIC50:  0.280nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559665(WO2022109117, Example 10)
Affinity DataIC50:  0.300nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559746(WO2022109117, Example 91)
Affinity DataIC50:  0.300nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559713(WO2022109117, Example 58)
Affinity DataIC50:  0.300nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559674(WO2022109117, Example 19)
Affinity DataIC50:  0.300nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559751(WO2022109117, Example 96)
Affinity DataIC50:  0.320nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559700(WO2022109117, Example 45)
Affinity DataIC50:  0.320nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp &Amp

WIPO
LigandPNGBDBM559723(WO2022109117, Example 68)
Affinity DataIC50:  0.330nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
Displayed 1 to 50 (of 5978 total ) | Next | Last >>
Jump to: